Levels of FABP2 and IL-10 were significantly higher in HCC patients vs. control group (median 2345 vs. 1327 pg/mL, p = 0.026; 9.94 vs. 4.89 pg/mL, p < 0.001). This evidence concerns the gene IL10 and hepatocellular carcinoma.